Focused conversation on precision medicine, including MMR testing, advanced treatment options, and the potential for non-surgical approaches in gastrointestinal malignancies.
Safe, Robust Responses Observed With Amphiphile Lymph Node-Targeted Vaccine in MRD+ PDAC and CRC
mKRAS-specific T-cell responses that were produced by ELI-002 7P correlated with tumor biomarker responses among patients with pancreatic and colorectal cancer.
Read More
LaPelusa’s Journey in the Dynamic Field of GI Oncology
In this episode of Emerging Experts, Michael LaPelusa, MD, shares his insights, experiences, and passion for cancer research, particularly in the realm of gastrointestinal cancers.
Listen
Perioperative Chemotherapy Prolongs OS in Esophageal Cancer
Perioperative chemotherapy with improved OS vs neoadjuvant chemoradiation in resectable esophageal cancer.
Unpacking the Latest Research in Gastrointestinal Cancers
In season 4, episode 1 of Targeted Talks, Benjamin L. Schlechter, MD, discuses new studies in the gastrointestinal cancers space.
VCN-01 Plus Chemo Wins FDA Fast Track Designation in Pancreatic Cancer
VCN-01, an adenovirus therapy, received fast track designation from the FDA for treating metastatic pancreatic cancer in combination with standard chemotherapy.
FDA Withdraws Infigratinib Approval for Cholangiocarcinoma
The FDA has withdrawn the approval for infigratinib to treat patients with cholangiocarcinoma. A phase 3 study comparing it to standard treatment has also been halted.